Thomas Raffin

Thomas A. Raffin is the founder of Rigel Pharmaceuticals, Inc. (1996) and Telegraph Hill Partners Management Co. LLC (2001) where the title held is Venture Partner.
Dr. Raffin is also the founder of Stanford University Center For Biomedical Ethics.
Current jobs include Director at LDR Spine USA, Inc., Director at Invisalert Solutions, Inc., Director at Viewpoint Molecular Targeting, Inc., and Professor-Emeritus at Stanford University School of Medicine.
Former jobs include Director at Akoya Biosciences, Inc. (2015-2025), Lead Independent Director at NewLink Genetics Corp., Director at PneumRx LLC, Director at AngioScore LLC, Director at LDR Holding Corp., Director at Confirma, Inc., Director at The Magstim Co. Ltd., Director at Freedom Innovations LLC, Director at Aquaro Histology, Inc., Director at TrakCel Ltd., and Lead Independent Director at Lumos Pharma, Inc. (2010-2024).
Education includes an undergraduate degree from Stanford University and a doctorate from Stanford University School of Medicine.